论文部分内容阅读
随着免疫抑制疗法的应用,疱疹病毒性视网膜炎的报告不断增多,治疗更宜减少免疫抑制剂的用量并给予全身性抗病毒药。作者测试了玻璃体内抗病毒药物(Vidarabine和acyclovir)的毒性。
With the application of immunosuppressive therapy, the report of herpes viral retinitis continues to increase, the treatment is more appropriate to reduce the dosage of immunosuppressive agents and systemic systemic antivirals. The authors tested the toxicity of intravitreal antiviral drugs (Vidarabine and acyclovir).